zolmitriptan has been researched along with chitosan in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Alhalaweh, A; Andersson, S; Velaga, SP | 1 |
| Alhalaweh, A; Gavini, E; Rassu, G; Velaga, SP; Vilinska, A | 1 |
| Alhalaweh, A; Bandiera, P; Beggiato, S; Dalpiaz, A; Ferraro, L; Gavini, E; Giunchedi, P; Marchetti, N; Rassu, G; Velaga, S | 1 |
| Kaur, G; Kaur, K | 1 |
| Chaudhari, PR; Mandlik, SK; Mohanty, BS; Ranpise, NS | 1 |
| Bukka, R; Khezri, FANZ; Lakshmi, CSR; Nargund, SL; Nidhi, M | 1 |
| Awadeen, RH; Boughdady, MF; Meshali, MM | 1 |
7 other study(ies) available for zolmitriptan and chitosan
| Article | Year |
|---|---|
Preparation of zolmitriptan-chitosan microparticles by spray drying for nasal delivery.
Topics: Administration, Intranasal; Capsules; Chemistry, Pharmaceutical; Chitosan; Drug Delivery Systems; Oxazolidinones; Particle Size; Powders; Tryptamines; X-Ray Diffraction | 2009 |
Surface thermodynamics of mucoadhesive dry powder formulation of zolmitriptan.
Topics: Adhesiveness; Animals; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Drug Compounding; Hypromellose Derivatives; Methylcellulose; Molecular Weight; Mucins; Nasal Mucosa; Oxazolidinones; Powders; Serotonin 5-HT1 Receptor Agonists; Surface Properties; Sus scrofa; Technology, Pharmaceutical; Thermodynamics; Tryptamines | 2011 |
Influence of polymeric microcarriers on the in vivo intranasal uptake of an anti-migraine drug for brain targeting.
Topics: Adhesives; Administration, Intranasal; Administration, Intravenous; Animals; Area Under Curve; Brain; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Glutamic Acid; Hypromellose Derivatives; Migraine Disorders; Nasal Mucosa; Oxazolidinones; Permeability; Polymers; Powders; Swine; Tryptamines | 2013 |
Formulation and evaluation of chitosan-chondroitin sulphate based nasal inserts for zolmitriptan.
Topics: Administration, Intranasal; Brain; Chemistry, Pharmaceutical; Chitosan; Chondroitin Sulfates; Drug Delivery Systems; Humans; Microscopy, Electron, Scanning; Migraine Disorders; Oxazolidinones; Serotonin 5-HT1 Receptor Agonists; Tryptamines | 2013 |
A coupled bimodal SPECT-CT imaging and brain kinetics studies of zolmitriptan-encapsulated nanostructured polymeric carriers.
Topics: Administration, Intranasal; Administration, Intravenous; Animals; Brain; Chitosan; Drug Carriers; Kinetics; Male; Mice; Nanostructures; Oxazolidinones; Polyphosphates; Serotonin 5-HT1 Receptor Agonists; Technetium; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tryptamines | 2018 |
Pharmacokinetic study and brain tissue analysis of Zolmitriptan loaded chitosan nanoparticles in rats by LC-MS method.
Topics: Administration, Intranasal; Animals; Brain; Chitosan; Chromatography, Liquid; Disease Models, Animal; Male; Migraine Disorders; Nanoparticles; Oxazolidinones; Particle Size; Rats; Rats, Wistar; Tandem Mass Spectrometry; Tryptamines | 2020 |
Quality by Design Approach for Preparation of Zolmitriptan/Chitosan Nanostructured Lipid Carrier Particles - Formulation and Pharmacodynamic Assessment.
Topics: Animals; Capsules; Chitosan; Drug Carriers; Emulsions; Gelatin; Lipids; Male; Mice; Nanoparticles; Nanostructures; Oxazolidinones; Particle Size; Pectins; Polysorbates; Solubility; Tryptamines; Ultrasonics | 2020 |